Abstract:
AIM To evaluate the relationship between alternation of intestinal flora composition and its metabolites and the progression of atrial fibrillation.
METHODS Fifty-nine patients were consecutively enrolled and were divided into sinus rhythm (SR) group (n=11), paroxysmal AF (PaAF) group (n=23) and persistent AF (PeAF) group (n=25). 16S rRNA sequencing and liquid chromatography were employed for the analysis of gut microbiota composition and serum TMAO, carnitine and choline levels, respectively.
RESULTS At the phylum level, Bacteroidetes accounted for 76.6% of the gut microbiota in the SR group and 69.1% in the PaAF group, significantly higher than 45.0% in the PeAF group (both P<0.01); There was no statistically significant difference between the two groups; Firmicutes accounted for 18.7% of the gut microbiota in the SR group and 29.7% in the PaAF group, significantly lower than the 52.0% in the PeAF group (both P<0.01), and there was no statistically significant difference between the two groups. The proportion of other bacterial types such as Actinobacteria, Proteobacteria, and Verrucomicrobia is relatively low, and there is no statistically significant difference among the three groups. There was no statistically significant difference in the composition of most bacterial species among the SR group, PaAF group, and PeAF groups at the family level. PCA analysis suggests that the composition of gut microbiota is similar between the SR group and the PaAF group, but significantly different from the PeAF group. The expression levels of serum trimethylamine (TMAO), carnitine, and choline showed an increasing trend among the three groups, with values of 1.21, respectively μmol/L, 2.49 μmol/L and 3.28 μmol/L; 34.85 μmol/L, 38.20 μmol/L and 46.47 μmol/L; 10.41 μmol/L, 15.18 μmol/L and 18.49 μmol/L, the difference is statistically significant (trend P-values are all<0.01).
CONCLUSION The alternation of intestinal flora composition and its metabolites, including TMAO, Carnitineand Choline, are associated with the progression of AF, indicating that gut flora might be an underlying risk factor for AF development.